These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 16215864)
1. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Slattery ML; Baumgartner KB; Byers T; Guiliano A; Sweeney C; Herrick J; Curtin K; Murtaugh M; Wolff R Cancer Causes Control; 2005 Dec; 16(10):1147-57. PubMed ID: 16215864 [TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Rollison DE; Giuliano AR; Risendal BC; Sweeney C; Boulware D; Laronga C; Baumgartner KB; Byers T; Slattery ML Breast Cancer Res Treat; 2010 Jun; 121(3):661-9. PubMed ID: 19888649 [TBL] [Abstract][Full Text] [Related]
3. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status. Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750 [TBL] [Abstract][Full Text] [Related]
4. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426 [TBL] [Abstract][Full Text] [Related]
5. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087 [TBL] [Abstract][Full Text] [Related]
6. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922 [TBL] [Abstract][Full Text] [Related]
7. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444 [TBL] [Abstract][Full Text] [Related]
8. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS; PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Sweeney C; Murtaugh MA; Baumgartner KB; Byers T; Giuliano AR; Herrick JS; Wolff R; Caan BJ; Slattery ML Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1802-9. PubMed ID: 16030120 [TBL] [Abstract][Full Text] [Related]
10. Genetic and dietary determinants of insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 levels among Chinese women. Wang Q; Liu L; Li H; McCullough LE; Qi YN; Li JY; Zhang J; Miller E; Yang CX; Smith JS PLoS One; 2014; 9(10):e108934. PubMed ID: 25285521 [TBL] [Abstract][Full Text] [Related]
11. Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort. Monson KR; Goldberg M; Wu HC; Santella RM; Chung WK; Terry MB Breast Cancer Res; 2020 Oct; 22(1):109. PubMed ID: 33092613 [TBL] [Abstract][Full Text] [Related]
12. ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States. Slattery ML; Sweeney C; Herrick J; Wolff R; Baumgartner K; Giuliano A; Byers T Breast Cancer Res Treat; 2007 Nov; 105(3):327-35. PubMed ID: 17187234 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Gapstur SM; Kopp P; Chiu BC; Gann PH; Colangelo LA; Liu K Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2208-16. PubMed ID: 15598782 [TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor-I and breast cancer. Toniolo P; Bruning PF; Akhmedkhanov A; Bonfrer JM; Koenig KL; Lukanova A; Shore RE; Zeleniuch-Jacquotte A Int J Cancer; 2000 Dec; 88(5):828-32. PubMed ID: 11072255 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221 [TBL] [Abstract][Full Text] [Related]
16. IGF-I and mammographic density in four geographic locations: a pooled analysis. Maskarinec G; Takata Y; Chen Z; Gram IT; Nagata C; Pagano I; Hayashi K; Arendell L; Skeie G; Rinaldi S; Kaaks R Int J Cancer; 2007 Oct; 121(8):1786-92. PubMed ID: 17520679 [TBL] [Abstract][Full Text] [Related]
17. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort. Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047 [TBL] [Abstract][Full Text] [Related]
19. Polymorphic variation at the -202 locus in IGFBP3: Influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Schernhammer ES; Hankinson SE; Hunter DJ; Blouin MJ; Pollak MN Int J Cancer; 2003 Oct; 107(1):60-4. PubMed ID: 12925957 [TBL] [Abstract][Full Text] [Related]
20. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Jernström H; Chu W; Vesprini D; Tao Y; Majeed N; Deal C; Pollak M; Narod SA Mol Genet Metab; 2001 Feb; 72(2):144-54. PubMed ID: 11161840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]